Stada Group
Mirabela Sangerean is a highly experienced professional in the pharmaceutical sector, currently serving as the Manager of Global Quality Agreements at STADA Group since February 2016. Additionally, Mirabela holds positions as Deputy Team Leader for Global Quality Supplier and Vendor Qualification and as a Corporate QA Specialist within the same organization. Since April 2018, Mirabela has also worked as a Freelance Translator for Swiss Solutions. Mirabela Sangerean obtained a Bachelor of Pharmacy degree from Victor Babeş University of Medicine and Pharmacy in Timişoara, completing the program in 2015.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.